Insulin Resistance (cont.)
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Robert Ferry Jr., MD
Robert Ferry Jr., MD, is a U.S. board-certified Pediatric Endocrinologist. After taking his baccalaureate degree from Yale College, receiving his doctoral degree and residency training in pediatrics at University of Texas Health Science Center at San Antonio (UTHSCSA), he completed fellowship training in pediatric endocrinology at The Children's Hospital of Philadelphia.
In this Article
- Insulin resistance facts
- What is insulin resistance?
- What causes insulin resistance?
- What is the relationship between insulin resistance and diabetes?
- What medical conditions are associated with insulin resistance?
- Who is at risk for insulin resistance?
- How is insulin resistance diagnosed?
- How is insulin resistance managed?
- Lifestyle changes (diet, weight loss, exercise)
- What's new in insulin resistance?
- Find a local Endocrinologist in your town
What's new in insulin resistance?
Over the past decade, insulin resistance has gained significance, in its own right, as a contributor to the metabolic syndrome. Timely intervention can delay the onset of overt type 2 diabetes. Future studies must assess longer intervals than research to date in order to determine the duration for treatment to prevent the development of type 2 diabetes and related complications.
Lifestyle changes (in nutrition and physical activity) are clearly important to delay the development of type 2 diabetes in individuals with insulin resistance and are the primary recommendation for prevention of diabetes in high-risk individuals. Metformin is the only drug recommended by guidelines, for those patients at highest risk. Education about these changes must be directed to all groups at risk for type 2 diabetes. Childhood obesity is epidemic and on the rise in the developed countries. Changes must be made in homes and school cafeterias to ensure healthier nutrition.
MedscapeReference. Insulin Resistance.
National Diabetes Information Clearinghouse (NDIC). Diabetes Prevention Program (DPP)
National Diabetes Information Clearinghouse (NDIC). Insulin resistance and prediabetes.
Viewers share their comments
Find out what women really need.